CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 20 enrolled
Drug / intervention
Minocyclinedrug
Likely dose
Minocycline 300mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01514422
NCT01514422Phase 4Completed
CompareCT.gov

Minocycline for Bipolar Disorder

Icahn School of Medicine at Mount Sinai·interventional·Posted Jan 23, 2012·Updated Jan 30, 2017

In Brief

A Phase 4 clinical trial evaluating Minocycline for Bipolar Depression. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate minocycline as a potential treatment for bipolar depression when added to a mood-stabilizing medication. Minocycline is an antibiotic that is approved for the treatment of infections and acne. Participation in this research study is expected to last 8 weeks, and includes five outpatient visits.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBipolar Depression
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJan 23, 2012
Enrollment StartMay 1, 2011
Primary CompletionAug 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 14.4 years ago

Interventions

Minocyclinedrug

Minocycline 100 to 300mg per day for 8 weeks